1. Medtech Insight
  2. >>Geography
  3. >>North America
  4. >>United States

Wireless Technology And The Rise Of “Anywhere” Monitoring

The emerging market for wireless and remote monitoring technologies comes at a time when providers are looking for new tools to not only keep patients out of the hospital, but also to prevent unnecessary readmissions. These goals, along with a growing list of enabling technologies in the pipeline, are helping drive health care toward an era of unprecedented connectivity – one in which physicians and other care givers are able to monitor and even treat patients whenever needed wherever they may be – a shift that many believe will profoundly change health care as we know it.

The health care industry is still in the early stages of a technological revolution involving wireless and remote technology; however, the changes that have already taken place have been profound. Most young physicians today – as well as those still in medical school – will never know a way of practicing medicine that does not include wireless, mobile devices such as smartphones and tablets. In fact, there is substantial interest among physicians in using wireless devices to perform a variety of clinical tasks, according to a survey conducted in 2010. (See Exhibit 1.) But for all the changes that have already occurred, there are even more pioneering ideas that continue to push their way into the spotlight as device manufacturers, software developers, and other innovators look for the right tools to address health care’s most pressing needs.

Some of the first innovations are coming from companies developing wireless, remote monitoring technology, which has emerged as a tool...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

FDA ‘Regulatory Accelerator’ Aims To Speed Digital Health Development

 
• By Elizabeth Orr

The US FDA has launched the Regulatory Accelerator to expedite digital health product development. This includes resources like a Resource Index for Innovators, a Medical Device Software Guidance Navigator, and best practices for early meetings.

From ‘Work Harder’ to ‘Phenomenal People’: Makary’s FDA About-Face

 
• By Michael McCaughan

In his first 100 days as FDA commissioner, Martin Makary has gone from vocal critic to vocal supporter of the agency’s staff, calling them “phenomenal” and praising their dedication—even as morale remains shaken by recent layoffs and restructuring.

Medtech M&A Resurges: How To Define Startup Exit Strategy

 
• By Natasha Barrow

The medtech M&A landscape is experiencing a resurgence fueled by significant capital from private equity and venture firms, says Alex Wakefield, CRO of AcuityMD. Building strong relationships with physicians remains crucial in medtech, and defining an exit strategy early is imperative.

HHS Suggests Drastic Reductions To Skin Substitute Payments

 
• By Elizabeth Orr

The US Department of Health and Human Services has proposed cutting Medicare reimbursement for skin substitutes used in chronic wound care by up to 90%. The change aims to address rising costs but could harm patient access and treatment quality, prompting concerns from industry stakeholders.

More from North America

Medtech M&A Resurges: How To Define Startup Exit Strategy

 
• By Natasha Barrow

The medtech M&A landscape is experiencing a resurgence fueled by significant capital from private equity and venture firms, says Alex Wakefield, CRO of AcuityMD. Building strong relationships with physicians remains crucial in medtech, and defining an exit strategy early is imperative.

HHS Suggests Drastic Reductions To Skin Substitute Payments

 
• By Elizabeth Orr

The US Department of Health and Human Services has proposed cutting Medicare reimbursement for skin substitutes used in chronic wound care by up to 90%. The change aims to address rising costs but could harm patient access and treatment quality, prompting concerns from industry stakeholders.

Injuries And Deaths Linked To Baxter Infusion Pump

 
• By Brian Bossetta

The US FDA says Baxter has notified customers about an issue with its Novum IQ Syringe Pump that is linked to two deaths and multiple injuries.